Literature DB >> 9479561

Bone mineral density and bone metabolism in diabetes mellitus.

B Piepkorn1, P Kann, T Forst, J Andreas, A Pfützner, J Beyer.   

Abstract

The effect of diabetes mellitus on bone metabolism and bone mineral density is discussed controversially. Diabetes mellitus due to an autoimmune process seems to be associated with low turnover osteopenia either in the animal model or in children and adolescents. A number of factors are discussed as being involved, but in this age group clinical symptoms are missing. Adult patients of either sex with IDDM show a reduced bone mineral density when measured at peripheral sites such as the distal forearm or the femoral neck, diabetic complications such as neuropathy and microangiopathy seem to pronounce the deficit of bone mass. In these patients, osteopenia is accompanied by a high turnover situation of bone metabolism, possibly due to microvascular complications. In contrast, patients with NIDDM and here especially overweight women have a normal or even increased bone mineral density. Up to now, there is no convincing evidence for an increased incidence of osteoporotic fractures in diabetic patients. Systemic diabetic osteopenia therefore does not seem to be of great epidemiological relevance.

Entities:  

Mesh:

Year:  1997        PMID: 9479561     DOI: 10.1055/s-2007-979106

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  25 in total

1.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

2.  Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

Authors:  T Shibata; S Takeuchi; S Yokota; K Kakimoto; F Yonemori; K Wakitani
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

3.  Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.

Authors:  N Ogata; D Chikazu; N Kubota; Y Terauchi; K Tobe; Y Azuma; T Ohta; T Kadowaki; K Nakamura; H Kawaguchi
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 4.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

5.  Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus.

Authors:  S Gul Oz; Gulay Sain Guven; Alpaslan Kilicarslan; Nursel Calik; Yavuz Beyazit; Tumay Sozen
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

Review 6.  Bone-Fat Interaction.

Authors:  Elizabeth Rendina-Ruedy; Clifford J Rosen
Journal:  Endocrinol Metab Clin North Am       Date:  2016-11-24       Impact factor: 4.741

7.  Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

Authors:  Sergiu Botolin; Marie-Claude Faugere; Hartmut Malluche; Michael Orth; Ron Meyer; Laura R McCabe
Journal:  Endocrinology       Date:  2005-05-19       Impact factor: 4.736

Review 8.  Osteoporosis and diabetes.

Authors:  Diane L Chau; Steven V Edelman; Manju Chandran
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

9.  Long-term fracture risk following renal transplantation: a population-based study.

Authors:  Line M Vautour; L Joseph Melton; Bart L Clarke; Sara J Achenbach; Ann L Oberg; James T McCarthy
Journal:  Osteoporos Int       Date:  2003-12-09       Impact factor: 4.507

10.  Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study.

Authors:  V Rakic; W A Davis; S A P Chubb; F M A Islam; R L Prince; T M E Davis
Journal:  Diabetologia       Date:  2006-03-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.